EUVIMEDEUVIMED entdecken
Open Access

Glycosphingolipids-Dependent Phospholipid Metabolism Enhances Cancer Initiation and Progression through SMPD1/GLTP/B3GALT4/ST8SIA6 Signaling Axis: A Novel Therapeutic Target

Liangpan Shi, Nanqi Mao, Zhihua Zheng, Jiangrui Liu, Hao Zhou, Jianbin Hou, Yibin Su

International Journal of Medical Sciences · 2025

DOI: 10.7150/ijms.103834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Liangpan Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, 362002, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Glycosphingolipids, Phospholipids. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a prevalent malignancy with high morbidity and mortality rates globally. Advances in single-cell sequencing technology have enabled comprehensive analyses of tumor cells at single-cell resolution, providing valuable insights into the molecular mechanisms underlying CRC initiation and progression. In this study, we integrated single-cell sequencing data with the TCGA database to identify key molecular pathways involved in CRC pathogenesis. Our analysis revealed that dysregulation of phospholipid metabolism, particularly sphingolipid metabolism, plays a crucial role in CRC development. Specifically, we observed aberrant expression of genes involved in sphingolipid biosynthesis and degradation, as well as altered levels of various sphingolipid metabolites in CRC cells. Furthermore, we identified several potential therapeutic targets, including SMPD1, GLTP, B3GALT4, and ST8SIA6, within the sphingolipid metabolism pathway that could be exploited for the development of novel CRC treatments. Overall, our findings provide novel insights into the molecular mechanisms underlying CRC and highlight the importance of targeting phospholipid metabolism, specifically sphingolipid metabolism, as a potential therapeutic strategy for CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsGlycosphingolipidsPhospholipidsHumansSignal TransductionGene Expression Regulation, NeoplasticCell Line, TumorDisease ProgressionGalactosyltransferasesSialyltransferasesN-Acetylgalactosaminyltransferases

Stichwörter der Autor:innen

Colorectal cancerMolecular mechanismsPhospholipid metabolismSingle-cell sequencing analysis

Substanzen

GlycosphingolipidsPhospholipidsGalactosyltransferasesSialyltransferasesN-Acetylgalactosaminyltransferases

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, 362002, China.

Zitieren

APA

Shi, L., Mao, N., Zheng, Z., Liu, J., Zhou, H., Hou, J., & Su, Y. (2025). Glycosphingolipids-Dependent Phospholipid Metabolism Enhances Cancer Initiation and Progression through SMPD1/GLTP/B3GALT4/ST8SIA6 Signaling Axis: A Novel Therapeutic Target. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.103834

Vancouver

Shi L, Mao N, Zheng Z, Liu J, Zhou H, Hou J, et al. Glycosphingolipids-Dependent Phospholipid Metabolism Enhances Cancer Initiation and Progression through SMPD1/GLTP/B3GALT4/ST8SIA6 Signaling Axis: A Novel Therapeutic Target. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.103834

BibTeX
@article{Shi2025,
  author = {Shi, Liangpan and Mao, Nanqi and Zheng, Zhihua and Liu, Jiangrui and Zhou, Hao and Hou, Jianbin and Su, Yibin},
  title = {Glycosphingolipids-Dependent Phospholipid Metabolism Enhances Cancer Initiation and Progression through SMPD1/GLTP/B3GALT4/ST8SIA6 Signaling Axis: A Novel Therapeutic Target},
  journal = {International Journal of Medical Sciences},
  year = {2025},
  doi = {10.7150/ijms.103834}
}
Kostenlos starten →